Journey Medical shareholders approve 3M-share increase to equity plan, re-elect directors

Journey Medical Corp

Shareholders approved amendment to 2015 Stock Plan increasing shares from 4,642,857 to 7,642,857 (a 64.6% increase).
All six director nominees elected: Rosenwald, Maraoui, Herskowitz, Paley, Smith, Toledano.
Ratification of KPMG as independent auditor for fiscal 2022 approved with 19,887,190 votes for.
Plan amendment became effective upon stockholder approval on June 21, 2022.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.